SLI
2.010,74
PKT
-11,91
PKT
-0,59
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.10.15 | Zurich Insurance buy | HSBC | |
| 09.10.15 | UBS Neutral | UBS AG | |
| 09.10.15 | Roche overweight | JP Morgan Chase & Co. | |
| 09.10.15 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 09.10.15 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
| 08.10.15 | Givaudan Neutral | Credit Suisse Group | |
| 08.10.15 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 07.10.15 | Givaudan buy | Deutsche Bank AG | |
| 07.10.15 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 07.10.15 | Givaudan Neutral | UBS AG | |
| 07.10.15 | UBS buy | Merrill Lynch & Co., Inc. | |
| 06.10.15 | Nestlé buy | Citigroup Corp. | |
| 06.10.15 | Nestlé overweight | Morgan Stanley | |
| 06.10.15 | Roche overweight | JP Morgan Chase & Co. | |
| 06.10.15 | Givaudan buy | Deutsche Bank AG | |
| 06.10.15 | Swiss Re Underperform | BNP PARIBAS | |
| 05.10.15 | UBS kaufen | Independent Research GmbH | |
| 05.10.15 | UBS Market Perform | Cowen and Company, LLC | |
| 05.10.15 | Nestlé buy | Nomura | |
| 05.10.15 | UBS overweight | Morgan Stanley | |
| 05.10.15 | UBS overweight | Morgan Stanley | |
| 02.10.15 | UBS Hold | Deutsche Bank AG | |
| 02.10.15 | UBS Hold | Deutsche Bank AG | |
| 02.10.15 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 02.10.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 02.10.15 | Givaudan overweight | JP Morgan Chase & Co. | |
| 01.10.15 | UBS kaufen | Kepler Cheuvreux | |
| 01.10.15 | Roche buy | HSBC | |
| 01.10.15 | Holcim overweight | JP Morgan Chase & Co. | |
| 30.09.15 | Roche overweight | JP Morgan Chase & Co. | |
| 30.09.15 | Roche buy | HSBC | |
| 29.09.15 | Roche overweight | JP Morgan Chase & Co. | |
| 29.09.15 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 29.09.15 | Holcim Reduce | HSBC | |
| 29.09.15 | Roche Outperform | BNP PARIBAS | |
| 28.09.15 | Roche buy | Kepler Cheuvreux | |
| 28.09.15 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.09.15 | Roche verkaufen | Goldman Sachs Group Inc. | |
| 25.09.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.09.15 | Roche buy | Deutsche Bank AG |